Stock MOLNRIPO J. MOLNER
Add to a list
To use this feature you must be a member
Log inSign up

Highlights J. Molner

Equities

MOLNRIPO

EE3100109034

Market Closed - Nasdaq Tallinn
Other stock markets
 14:30:00 14/06/2024 BST 		5-day change 1st Jan Change
13.8 EUR +4.55% Intraday chart for J. Molner 0.00% +0.36%
04-30 J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4% CI
03-04 J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%
CI
J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services
CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US
CI
J. Molner AS has completed an IPO in the amount of Ç1.199998 million.
CI
J. Molner AS has filed an IPO in the amount of Ç1.199998 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOLNRIPO Stock
  4. News J. Molner
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW